Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.07B |
| 2 |
ExxonMobil
XOM
|
+$648M |
| 3 |
Merck
MRK
|
+$572M |
| 4 |
MetLife
MET
|
+$383M |
| 5 |
Chevron
CVX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$798M |
| 2 |
AbbVie
ABBV
|
+$625M |
| 3 |
TSMC
TSM
|
+$622M |
| 4 |
Cisco
CSCO
|
+$507M |
| 5 |
Goldman Sachs
GS
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.86% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.44% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Century Therapeutics
IPSC
$349M
| $107K | ﹤0.01% |
105,529
-465
| -0.4% | -$633 |
|
3902
Werewolf Therapeutics
HOWL
$18.9M
| $106K | ﹤0.01% |
71,300
+13,372
| +23% | +$27.3K |
|
3903
Purple Innovation
PRPL
$28.9M
| $105K | ﹤0.01% |
5,403
| – | – |
|
3904
Village Farms International
VFF
$309M
| $104K | ﹤0.01% |
135,467
| – | – |
|
|
CODX
3905
Co-Diagnostics
CODX
$5.49M
| $103K | ﹤0.01% |
4,569
| – | – |
|
3906
Cibus
CBUS
$153M
| $101K | ﹤0.01% |
36,508
+70
| +0.2% | +$271 |
|
3907
FibroBiologics
FBLG
$7.52M
| $101K | ﹤0.01% |
2,520
| – | – |
|
|
JBIO
3908
Jade Biosciences
JBIO
$1.49B
| $99.8K | ﹤0.01% |
1,076
-109
| -9% | -$9.39K |
|
3909
Annovis Bio
ANVS
$76.1M
| $95.9K | ﹤0.01% |
19,058
-1
| -0% | -$7 |
|
3910
Wipro
WIT
$19.3B
| $90.1K | ﹤0.01% |
25,451
-3,749
| -13% | -$12.8K |
|
|
AISP
3911
Airship AI Holdings
AISP
$66.5M
| $89.8K | ﹤0.01% |
+14,338
| New | +$42.2K |
|
3912
Arcos Dorados Holdings
ARCO
$1.72B
| $89.3K | ﹤0.01% |
12,272
+1,830
| +18% | +$15.7K |
|
3913
Fractyl Health
GUTS
$111M
| $85.4K | ﹤0.01% |
41,448
+8,886
| +27% | +$20.7K |
|
3914
Nuveen California Municipal Value Fund
NCA
$304M
| $85.1K | ﹤0.01% |
10,071
-134
| -1% | -$1.18K |
|
|
LUNA
3915
DELISTED
Luna Innovations Incorporated
LUNA
| $85.1K | ﹤0.01% |
39,390
-17,031
| -30% | -$30.1K |
|
|
BIOA
3916
BioAge Labs
BIOA
$485M
| $85K | ﹤0.01% |
+14,685
| New | +$253K |
|
3917
Lantern Pharma
LTRN
$34.1M
| $84.5K | ﹤0.01% |
26,482
| – | – |
|
|
VCSA
3918
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $84.3K | ﹤0.01% |
17,204
| – | – |
|
3919
Protara Therapeutics
TARA
$234M
| $83.9K | ﹤0.01% |
15,883
-2,024
| -11% | -$6.54K |
|
3920
Actinium Pharmaceuticals
ATNM
$29.2M
| $82.3K | ﹤0.01% |
65,311
-215
| -0.3% | -$334 |
|
3921
Telefônica Brasil
VIV
$18.2B
| $81.4K | ﹤0.01% |
+10,787
| New | +$96K |
|
|
OPTN
3922
DELISTED
OptiNose
OPTN
| $81.3K | ﹤0.01% |
12,178
-1
| -0% | -$9 |
|
|
MRDN
3923
Meridian Holdings Inc
MRDN
$178M
| $80.5K | ﹤0.01% |
3,386
+672
| +25% | +$18.7K |
|
|
CGAU
3924
Centerra Gold
CGAU
$4.14B
| $80.3K | ﹤0.01% |
14,112
-40,312
| -74% | -$259K |
|
3925
Roadzen
RDZN
$117M
| $79.7K | ﹤0.01% |
36,554
+10,295
| +39% | +$12.7K |
|
Similar funds
Bank of New York Mellon's Q4 2024 Portfolio in Review
As of Q4 2024, Bank of New York Mellon held 4,232 positions worth $541B, up 0.69% from $538B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Bank of New York Mellon's Q4 2024 filing shows 139 new, 1,799 increased, 1,997 reduced and 116 closed positions. Its largest new stake was Fidelity Total Bond ETF: 1,758,308 shares worth $78.9M. The largest sale was Broadcom, an estimated $798M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2024 buy was Fidelity Total Bond ETF: 1,758,308 shares worth $78.9M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $1.07B increase.
- Bank of New York Mellon's biggest Q4 2024 reduction was Broadcom, cutting an estimated $798M.
- Bank of New York Mellon fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $131M.
- Bank of New York Mellon's ten largest holdings make up 26% of its $541B portfolio in Q4 2024.
- Bank of New York Mellon opened 139 new positions and closed 116 in Q4 2024.
- Bank of New York Mellon's portfolio value rose 0.69% quarter-over-quarter to $541B.
Based on Bank of New York Mellon's 13F filing for Q4 2024, filed 4 Feb 2025.